DAPK1
Basic information
Region (hg38): 9:87497228-87708634
Links
Phenotypes
GenCC
Source:
- autism spectrum disorder (Limited), mode of inheritance: AD
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the DAPK1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 16 | |||||
missense | 81 | 86 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 4 | 4 | ||||
non coding | 5 | |||||
Total | 0 | 0 | 81 | 14 | 12 |
Variants in DAPK1
This is a list of pathogenic ClinVar variants found in the DAPK1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
9-87499110-T-C | Likely benign (Oct 23, 2018) | |||
9-87499119-C-T | Likely benign (May 30, 2017) | |||
9-87499130-A-G | not specified | Uncertain significance (Jun 22, 2023) | ||
9-87604973-A-C | not specified | Uncertain significance (Jun 16, 2023) | ||
9-87604982-C-T | not specified | Uncertain significance (Nov 17, 2022) | ||
9-87605052-G-A | not specified | Uncertain significance (Sep 27, 2022) | ||
9-87605066-G-C | not specified | Uncertain significance (Dec 21, 2022) | ||
9-87637937-T-C | Benign (Oct 09, 2018) | |||
9-87637944-G-T | not specified | Uncertain significance (Oct 21, 2021) | ||
9-87637948-C-T | not specified | Uncertain significance (Oct 17, 2023) | ||
9-87638024-A-G | Benign (Dec 31, 2019) | |||
9-87638035-G-A | not specified | Uncertain significance (Sep 20, 2023) | ||
9-87638073-G-C | Myoepithelial tumor | Uncertain significance (Nov 01, 2022) | ||
9-87639461-A-G | not specified | Uncertain significance (Aug 12, 2021) | ||
9-87640307-G-A | Likely benign (Dec 11, 2018) | |||
9-87640366-A-G | not specified | Uncertain significance (Feb 08, 2023) | ||
9-87640437-G-A | not specified | Uncertain significance (Nov 28, 2023) | ||
9-87640793-C-G | Benign (Dec 31, 2019) | |||
9-87640823-T-G | not specified | Uncertain significance (Sep 14, 2023) | ||
9-87641974-A-C | not specified | Uncertain significance (Dec 03, 2021) | ||
9-87642034-G-T | not specified | Uncertain significance (Mar 26, 2024) | ||
9-87643366-T-A | Benign (Dec 31, 2019) | |||
9-87643367-A-T | Likely benign (Dec 31, 2019) | |||
9-87643366-T-TTA | Benign (Dec 31, 2019) | |||
9-87643404-A-G | not specified | Uncertain significance (Aug 02, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
DAPK1 | protein_coding | protein_coding | ENST00000408954 | 25 | 211406 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.998 | 0.00233 | 124898 | 0 | 22 | 124920 | 0.0000881 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.57 | 664 | 878 | 0.756 | 0.0000547 | 9394 |
Missense in Polyphen | 137 | 235.52 | 0.58169 | 2410 | ||
Synonymous | -0.600 | 386 | 371 | 1.04 | 0.0000256 | 2824 |
Loss of Function | 6.29 | 11 | 66.3 | 0.166 | 0.00000347 | 749 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000158 | 0.000151 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000556 | 0.0000556 |
Finnish | 0.0000469 | 0.0000464 |
European (Non-Finnish) | 0.0000975 | 0.0000970 |
Middle Eastern | 0.0000556 | 0.0000556 |
South Asian | 0.000133 | 0.000131 |
Other | 0.000166 | 0.000165 |
dbNSFP
Source:
- Function
- FUNCTION: Calcium/calmodulin-dependent serine/threonine kinase involved in multiple cellular signaling pathways that trigger cell survival, apoptosis, and autophagy. Regulates both type I apoptotic and type II autophagic cell deaths signal, depending on the cellular setting. The former is caspase-dependent, while the latter is caspase-independent and is characterized by the accumulation of autophagic vesicles. Phosphorylates PIN1 resulting in inhibition of its catalytic activity, nuclear localization, and cellular function. Phosphorylates TPM1, enhancing stress fiber formation in endothelial cells. Phosphorylates STX1A and significantly decreases its binding to STXBP1. Phosphorylates PRKD1 and regulates JNK signaling by binding and activating PRKD1 under oxidative stress. Phosphorylates BECN1, reducing its interaction with BCL2 and BCL2L1 and promoting the induction of autophagy. Phosphorylates TSC2, disrupting the TSC1-TSC2 complex and stimulating mTORC1 activity in a growth factor-dependent pathway. Phosphorylates RPS6, MYL9 and DAPK3. Acts as a signaling amplifier of NMDA receptors at extrasynaptic sites for mediating brain damage in stroke. Cerebral ischemia recruits DAPK1 into the NMDA receptor complex and it phosphorylates GRINB at Ser-1303 inducing injurious Ca(2+) influx through NMDA receptor channels, resulting in an irreversible neuronal death. Required together with DAPK3 for phosphorylation of RPL13A upon interferon-gamma activation which is causing RPL13A involvement in transcript- selective translation inhibition.;
- Pathway
- Bladder cancer - Homo sapiens (human);Autophagy - animal - Homo sapiens (human);Pathways in cancer - Homo sapiens (human);Bladder Cancer;Caspase activation via extrinsic apoptotic signalling pathway;Apoptosis;Programmed Cell Death;Ligand-independent caspase activation via DCC;IFN-gamma pathway;Netrin-mediated signaling events
(Consensus)
Recessive Scores
- pRec
- 0.105
Intolerance Scores
- loftool
- 0.291
- rvis_EVS
- -1.28
- rvis_percentile_EVS
- 5.19
Haploinsufficiency Scores
- pHI
- 0.182
- hipred
- Y
- hipred_score
- 0.639
- ghis
- 0.526
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.813
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Dapk1
- Phenotype
- homeostasis/metabolism phenotype; cellular phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);
Gene ontology
- Biological process
- protein phosphorylation;apoptotic process;extrinsic apoptotic signaling pathway via death domain receptors;regulation of autophagy;positive regulation of autophagy;negative regulation of translation;intracellular signal transduction;regulation of apoptotic process;negative regulation of apoptotic process;positive regulation of cysteine-type endopeptidase activity involved in apoptotic process;protein autophosphorylation;cellular response to interferon-gamma;cellular response to hydroperoxide;apoptotic signaling pathway;regulation of NMDA receptor activity
- Cellular component
- nucleus;cytoplasm;plasma membrane;actin cytoskeleton
- Molecular function
- protein kinase activity;protein serine/threonine kinase activity;calmodulin-dependent protein kinase activity;protein binding;calmodulin binding;ATP binding;GTP binding;syntaxin-1 binding;identical protein binding